Grade My Investments

Cencora, Inc. (COR) Stock Grade

COR · Healthcare

A+
Grade updated: September 29, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$59.1B
P/E Ratio
39.0
Revenue Growth (YoY)
+9.3%
Net Margin
0.5%
Return on Equity
103.1%
Dividend Yield
0.8%

About Cencora, Inc.'s fundamentals

Cencora is a healthcare distribution company with a market capitalization of $59.1 billion that generated 9.3% year-over-year revenue growth. The company operates on razor-thin margins with a net margin of just 0.5%, which is typical for large-scale distribution businesses handling high volumes of medical products. Despite modest profitability relative to sales, Cencora demonstrates exceptional capital efficiency with a return on equity of 103.1%, indicating it generates substantial profits from shareholder capital. The company offers a modest dividend yield of 0.8%, while trading at a P/E ratio of 39.0.

Track COR free — no credit card required. Live grade + monthly AI report →